Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.63 | 0.01 |
mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.02 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |
mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.02 |
mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.03 |